ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists develop a ‘third eye’ to examine stem cells – Phys.Org

Continue reading

2018-02-08 Michael Zand NEWS

Global Study Synthetic Biology Market Chain, Dynamics and Key Players 2016 – 2026 – Digital Journal

Edition TimeGlobal Study Synthetic Biology Market Chain, Dynamics and Key Players 2016 – 2026Digital JournalValley Cottage, NY — (SBWIRE) — 02/08/2018 — Synthetic Biology is one of the breakthrough technologies developed by mankind from chemistry, b… Continue reading

2018-02-08 Michael Zand NEWS

Head to Head Comparison: Editas Medicine (EDIT) versus … – StockNewsTimes

Head to Head Comparison: Editas Medicine (EDIT) versus …StockNewsTimesEditas Medicine (NASDAQ: EDIT) and PAREXEL International (NASDAQ:PRXL) are both healthcare companies, but which is the superior business? We will contrast the two companies based o… Continue reading

2018-02-08 Michael Zand NEWS

Innovative Sensor Fights Cancer Stem Cells – Controlled Environments Magazine

Innovative Sensor Fights Cancer Stem CellsControlled Environments MagazineMost cancer deaths are caused by recurrent or metastatic tumors. Conventional therapies target rapidly dividing tumor cells, but are unable to eradicate the highly chemoresistant… Continue reading

2018-02-08 Michael Zand NEWS

Abeona’s Sanfilippo Gene Therapy Data Produces Encouraging Results – Pharmaceutical Processing


Phys.Org

Scientists develop a ‘third eye’ to examine stem cells
Phys.Org
A variety of tissues and organs, including the brain, harbor stem cells responsible for tissue renewal. Contrary to the popular belief that neurons do not regenerate, the adult brain has regions where so-called neurogenesis—the formation of new …
LVPEI develops mini human eyes with the help of stem cellsBSI bureau (press release)
+20% CAGR to Be Achieved by Stem Cell Assay in International Market by 2022 – Know Major Reasons for the Rise in …Digital Journal
Global Animal Stem Cell Therapy Market 2017 – VETSTEM BIOPHARMA, MediVet Biologic, J-ARM, Celavet, Magellan …Highland Mirror
PharmiWeb.com (press release) –Edition of Analyst
all 21 news articles »
Continue reading

2018-02-08 Michael Zand NEWS

Major Analyst Actions Under Review: CRISPR Therapeutics AG … – Post Analyst

Post AnalystMajor Analyst Actions Under Review: CRISPR Therapeutics AG …Post AnalystThe recently concluded session had traders exchanging CRISPR Therapeutics AG (NASDAQ:CRSP) high level. Roughly 2.03 million shares changed hands compared to the three… Continue reading

2018-02-08 Michael Zand NEWS

CRISPR method efficiently corrects DMD defect in heart tissue – Drug Target Review


UtahHerald.com

Abeona’s Sanfilippo Gene Therapy Data Produces Encouraging Results
Pharmaceutical Processing
Abeona Therapeutics announces new phase 1/2 safety and biopotency data of investigational gene therapy for Sanfilippo syndrome at WORLDSymposium. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and …
Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%Seeking Alpha
Why Abeona Therapeutics Jumped 14% on WednesdayMadison.com
Abeona Therapeutics (ABEO) Given Buy Rating at Maxim GroupThe Ledger Gazette
Wolcott Daily –StockNewsTimes –Zacks –Zacks
all 46 news articles »
Continue reading

2018-02-08 Michael Zand NEWS

Researchers uncover how cancer stem cells drive triple-negative breast cancer – Medical Xpress

Medical XpressResearchers uncover how cancer stem cells drive triple-negative breast cancerMedical XpressCleveland Clinic Lerner Research Institute researchers believe that an aggressive population of cancer cells, called cancer stem cells, is at the h… Continue reading

2018-02-08 Michael Zand NEWS
  • 1
  • …
  • 559
  • 560
  • 561
  • 562
  • 563
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Drug Target Review

CRISPR method efficiently corrects DMD defect in heart tissue
Drug Target Review
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient’s DNA, according to a …

and more »